Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 317, pseudogene (RN7SL317P)
- Target
- RN7SL317P
- Molecular classification
- Pseudogene, Non-coding RNA
01
Overview
RN7SL317P is a transcribed pseudogene derived from 7SL RNA loci. 7SL RNA itself is a component of the signal recognition particle (SRP), involved in halting and directing nascent protein synthesis to the endoplasmic reticulum membrane for secretion or membrane localization[3][1]. RN7SL pseudogenes (including RN7SL317P) do not code for functional SRP RNA but may be transcribed, leading to possible generation of noncoding RNAs with potential regulatory activity, such as acting as miRNA sponges, or contributing to chromatin modification[4]. There is no evidence that RN7SL317P is a classical drug target or receptor; its main significance is as a representative of noncoding, transcribed pseudogenes in the human genome.
- Other names
- 7SL pseudogeneRN7SL pseudogeneRN7SL317P7SL RNA pseudogene
02
Mechanism of action
None. Since RN7SL317P is not a drug target, no mechanisms of drug action exist.
03
Biological functions
Possible regulation by small RNAs derived from its transcript, potentially acting as a competing endogenous RNA or miRNA sponge, influencing gene expression indirectlyMay participate in epigenetic regulation or chromatin modification if transcribedNo direct role in signal transduction, cell cycle, apoptosis, or immune response is established for RN7SL317P itself
04
Disease associations
Although the parent 7SL RNA is implicated in cancer and viral infection biology, disease involvement specific to this pseudogene is not establishedNo strong evidence for a direct RN7SL317P role in cancer, inflammation, or other disease
05
Safety considerations
None, as it is not a therapeutic target. The existence of regulatory pseudogene RNAs is part of normal genome biology.
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 317, pseudogene (RN7SL317P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 317, pseudogene (RN7SL317P).